Evidence map›Paper›PMID 31999704›Full record

ArticlePLoS neglected tropical diseases2020

Post-elimination surveillance in formerly onchocerciasis endemic focus in Southern Mexico.

Nadia A Fernández-Santos, Thomas R Unnasch, Isabel C Rodríguez-Luna, Francisco Gibert Prado-Velasco, Adebiyi A Adeniran, Humberto Martínez-Montoya, Mario A Rodríguez-Pérez

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Use of Ov16-Based Serology for Post-Elimination Surveillance of Onchocerciasis in Ecuador.The American journal of tropical medicine and hygiene · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nadia A Fernández-SantosInstituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa, Tamaulipas, México.
Thomas R UnnaschCenter for Global Health Infectious Diseases Research, University of South Florida, Tampa, Florida, United States of America.
Isabel C Rodríguez-LunaInstituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa, Tamaulipas, México.
Francisco Gibert Prado-VelascoSecretaría de Salud del Estado de Chiapas, Tuxtla Gutiérrez, Chiapas, México.
Adebiyi A AdeniranInstituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa, Tamaulipas, México.
Humberto Martínez-MontoyaUnidad Académica Multidisciplinaria Reynosa Aztlan-Universidad Autónoma de Tamaulipas, Reynosa, Tamaulipas, México.ORCID 0000-0003-3228-0054
Mario A Rodríguez-PérezInstituto Politécnico Nacional, Centro de Biotecnología Genómica, Reynosa, Tamaulipas, México.ORCID 0000-0002-0905-6073
Instituto Politécnico Nacional · MXAutonomous University of Tamaulipas · MXSecretaria de Salud · HNUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAll formerly endemic communities of the Southern Chiapas focus of onchocerciasis in Mexico were treated with ivermectin until parasite transmission was eliminated by 2015. Transmission of onchocerciasis did not resume during a period of three years (2012-2014) following the final distribution of ivermectin in 2011; it was thus concluded that transmission remained undetectable without intervention. WHO thus declared the elimination of transmission of onchocerciasis from Mexico in 2015. METHODOLOGY/PRINCIPAL

findingsFrom 2016 to the present, post-elimination surveillance (PES) based on examination for suspected onchocercomas was performed in the former Southern Chiapas focus. Each year, over 60% of the total population (range = 85,347-104,106 individuals) of the formerly endemic communities were examined for onchocercomas. Thirty-four individuals were found harboring suspected onchocercomas in the PES surveys conducted from 2016-2019. Of these, one female of 7 years of age who had immigrated from a formerly endemic focus, harbored an infertile (sterile) female in the suspected onchocercoma; all others were negative. Skin biopsy assessments were performed from March through May 2017 in three communities where the female resided. None of the 83 individuals of the three communities examined by skin biopsy were mf positive. Similarly, none of the biopsies from the individuals were found to contain parasite DNA when tested by polymerase chain reaction-enzyme-linked immunosorbent assay (PCR-ELISA). CONCLUSIONS/SIGNIFICANCE: These provide support to the conclusion that onchocerciasis has been eliminated from Mexico.

Indexed as

Onchocerca volvulusPopulation SurveillanceAdolescentAdultAgedAnimalsChildChild, PreschoolDisease EradicationDNA, HelminthFemaleHumansInfantIvermectinMaleMass Drug AdministrationDNA, HelminthIvermectin

Identifiers

PMID31999704
PMCPMC7012445
OpenAlexW3003204420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.